TITLE

ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct -- a study protocol [ISRCTN08471887]

AUTHOR(S)
Joos, Stefanie; Rosemann, Thomas; Heiderhoff, Marc; Wensing, Michel; Ludt, Sabine; Gensichen, Jochen; Kaufmann-Kolle, Petra; Szecsenyi, Joachim
PUB. DATE
January 2005
SOURCE
BMC Public Health;2005, Vol. 5 Issue 1, p99
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Diabetes model projects in different regions of Germany including interventions such as quality circles, patient education and documentation of medical findings have shown improvements of HbA1c levels, blood pressure and occurrence of hypoglycaemia in before-after studies (without control group). In 2002 the German Ministry of Health defined legal regulations for the introduction of nationwide disease management programs (DMP) to improve the quality of care in chronically ill patients. In April 2003 the first DMP for patients with type 2 diabetes was accredited. The evaluation of the DMP is essential and has been made obligatory in Germany by the Fifth Book of Social Code. The aim of the study is to assess the effectiveness of DMP by example of type 2 diabetes in the primary care setting of two German federal states (Rheinland-Pfalz and Sachsen-Anhalt). Methods/Design: The study is three-armed: a prospective cluster-randomized comparison of two interventions (DMP 1 and DMP 2) against routine care without DMP as control group. In the DMP group 1 the patients are treated according to the current situation within the German-Diabetes-DMP. The DMP group 2 represents diabetic care within ideally implemented DMP providing additional interventions (e.g. quality circles, outreach visits). According to a sample size calculation a sample size of 200 GPs (each GP including 20 patients) will be required for the comparison of DMP 1 and DMP 2 considering possible drop-outs. For the comparison with routine care 4000 patients identified by diabetic tracer medication and age (> 50 years) will be analyzed. Discussion: This study will evaluate the effectiveness of the German Diabetes-DMP compared to a Diabetes-DMP providing additional interventions and routine care in the primary care setting of two different German federal states.
ACCESSION #
29361859

 

Related Articles

  • Clinical inertia in general practice: widespread and related to the outcome of diabetes care. Van Bruggen, Rykel; Gorter, Kees; Stolk, Ronald; Klungel, Olaf; Rutten, Guy // Family Practice;Dec2009, Vol. 26 Issue 6, p428 

    Background and aims. Clinical inertia is considered a major barrier to better care. We assessed its prevalence, predictors and associations with the intermediate outcomes of diabetes care.

  • Full Circle. Gall, Karin // Diabetes Forecast;Mar2002, Vol. 55 Issue 3, p104 

    Reflects on managing diabetes. Factors that led to the development of diabetes; Initial reaction to the disease; Factor that enabled a change in outlook about the disease.

  • Healthy lifestyle is the key to treating type 2 diabetes.  // Primary Health Care;Apr2009, Vol. 19 Issue 3, p5 

    The article discusses concerns about initial treatment of diabetes revealed in a study by the Diabetes UK charity. The study showed that more than one third of patients begin diabetes medication within one month of diagnosis. The first response recommended by the British National Institute for...

  • Using the Glitazones to Manage Diabetes. Sadovsky, Richard // American Family Physician;01/15/2001, Vol. 63 Issue 2, p369 

    Presents an abstract of the study `The Glitazones: Proceed With Caution,' by D. Krische, from the July 2000 issue of the `Western Journal of Medicine,' focusing on the management of diabetes.

  • Management of diabetes mellitus in clinical practice. Lawal, Muili // British Journal of Nursing;9/25/2008, Vol. 17 Issue 17, p1106 

    Diabetes is a global health problem, with a challenging epidemiology. It is one of the major health problems affecting countries around the world, particularly the UK (World Health Organization [WHO], 2006; Department of Health [DH], 2006b). It is also a growing public health threat in the US...

  • Triple Therapy with Liraglutide + Metformin + Insulin Detemir Improves Glycemic Control With No Weight Gain and Low Rates of Hypoglycemia. Vinall, Maria // MD Conference Express;Dec2011, p15 

    The article discusses the triple therapy for type 2 diabetes mellitus (T2DM) with liraglutide, metformin, and insulin detemir. Doctor Stephen C. Bain of the Institute of Life Sciences in Swansea University in Wales, presented data that showed combination of triple therapy eliciting significant...

  • Managing diabetes at night.  // Asian Pacific Post;12/6/2012, Special section p8 

    The article presents tips on managing diabetes at night.

  • Diabetes Working Group releases recommendations for eliminating obstacles to diabetes care.  // Endocrine Today;Mar2012, Vol. 10 Issue 3, p20 

    The article outlines the recommendations for eliminating obstacles to diabetes care contained in the white paper released by the Diabetes Working Group.

  • Diabetes: Tight control works.  // Consumer Reports on Health;Dec98, Vol. 10 Issue 12, p5 

    Discusses the benefits of aggressive therapy for type I and II diabetes, according to a study by Oxford University researchers.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics